ExplORer Surgical Launches New Remote Case Support Features, Updating Real-Time Audio, Video and Data Collection Capabilities

ExplORer Surgical, the only comprehensive intraoperative case support and workflow platform, today announces the launch of remote features that connect reps and peers with the surgical team for real-time guidance. The HIPAA compliant, two-way video for case support and remote proctoring add to the platform’s existing and unique procedural workflow features that create the first digitized playbook for everyone in surgery. The platform allows for telestration and gathers intraoperative performance data to allow teams to increase efficiency and proficiency.

ExplORer Surgical points out that remote case support is increasingly critical due to COVID-19, where strict regulations limit travel and the number of personnel in the operating room. Medical device experts need a reliable way to communicate, and show how to safely and efficiently perform procedures. Alongside the video feed, the entire surgical team receives step-by-step, role-specific digital procedure workflows and tailored instructions, allowing them to be better prepared in the moment and ensuring better patient outcomes. Informed by data, surgical teams can identify clear opportunities for improvement, improving outcomes that ultimately, drive adoption and revenue gains for the device company over time.

“Travel restrictions and social distancing are impacting every area of life, and the OR is no exception,” said Jennifer Fried, CEO of ExplORer Surgical. “The medical device rep’s ability to guide the team through a complicated procedure using a robust digital toolset while being completely remote is critical right now — and we see it staying this way for the foreseeable future. Our platform goes above and beyond having a camera in the room — we’re delivering custom support for each team member, and allowing them to gather and analyze data seamlessly.”

ExplORer’s platform is cloud-based and device agnostic, making it easily accessible on existing hardware in the OR, including mobile devices, desktop monitors, and TV screens. In addition to customized content for each team member in the OR, the platform collects data, allows staff to record timestamps and save annotated images, and assists in creating actionable insights to improve inefficiencies. In addition, the company’s customer success team customizes hardware kits to make set-up and video integration simple and easy to use.

ExplORer provides meaningful value to all functions of an organization and the surgical teams they work with, including sales, training, medical affairs, marketing, and research and development.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”